GEP20186884B - Slow-release solid oral compositions - Google Patents
Slow-release solid oral compositionsInfo
- Publication number
- GEP20186884B GEP20186884B GEAP201414177A GEAP2014014177A GEP20186884B GE P20186884 B GEP20186884 B GE P20186884B GE AP201414177 A GEAP201414177 A GE AP201414177A GE AP2014014177 A GEAP2014014177 A GE AP2014014177A GE P20186884 B GEP20186884 B GE P20186884B
- Authority
- GE
- Georgia
- Prior art keywords
- slow
- solid oral
- oral compositions
- release solid
- excipient
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 229920001800 Shellac Polymers 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 abstract 1
- 239000004208 shellac Substances 0.000 abstract 1
- 229940113147 shellac Drugs 0.000 abstract 1
- 235000013874 shellac Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001906A ITMI20131906A1 (it) | 2013-11-18 | 2013-11-18 | Composizioni solide orali a lento rilascio |
| US201461989645P | 2014-05-07 | 2014-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20186884B true GEP20186884B (en) | 2018-07-25 |
Family
ID=49780196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP201414177A GEP20186884B (en) | 2013-11-18 | 2014-11-06 | Slow-release solid oral compositions |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10702482B2 (enExample) |
| EP (1) | EP3071191B1 (enExample) |
| JP (1) | JP6401270B2 (enExample) |
| KR (1) | KR102224087B1 (enExample) |
| CN (1) | CN105764493B (enExample) |
| AU (1) | AU2014349782B2 (enExample) |
| BR (1) | BR112016011142B1 (enExample) |
| CA (1) | CA2929426C (enExample) |
| DK (1) | DK3071191T3 (enExample) |
| EA (1) | EA039558B1 (enExample) |
| ES (1) | ES2908924T3 (enExample) |
| GE (1) | GEP20186884B (enExample) |
| HR (1) | HRP20220271T1 (enExample) |
| HU (1) | HUE058086T2 (enExample) |
| IL (1) | IL245167B (enExample) |
| IT (1) | ITMI20131906A1 (enExample) |
| LT (1) | LT3071191T (enExample) |
| MX (1) | MX367664B (enExample) |
| NZ (1) | NZ719000A (enExample) |
| PH (1) | PH12016500693A1 (enExample) |
| PL (1) | PL3071191T3 (enExample) |
| PT (1) | PT3071191T (enExample) |
| RS (1) | RS62916B1 (enExample) |
| UA (1) | UA119856C2 (enExample) |
| WO (1) | WO2015071806A1 (enExample) |
| ZA (1) | ZA201602659B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700074957A1 (it) * | 2017-07-04 | 2019-01-04 | Gnosis Spa | Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo |
| CN109939077B (zh) * | 2017-12-04 | 2022-07-22 | 深圳奥萨制药有限公司 | 一种含有5-甲基四氢叶酸的控释制剂 |
| CN111990674B (zh) * | 2020-01-14 | 2021-07-02 | 青岛圣邦健康食品有限公司 | 肠溶包衣材料及其制备方法和肠溶制品 |
| IT202000006127A1 (it) * | 2020-03-23 | 2021-09-23 | Fmc S R L | Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione |
| IT202300007692A1 (it) * | 2023-04-19 | 2024-10-19 | Vifra S R L | Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1200589B (it) * | 1985-02-14 | 1989-01-27 | Gibipharma Spa | Derivati naturali attivita farmagologica |
| ITMI20012462A1 (it) * | 2001-11-22 | 2003-05-22 | Gnosis Srl | Processo per la preparazione di compresse comprendenti s-adenosilmetionina |
| US20050181047A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements |
| JP2008519071A (ja) | 2004-11-05 | 2008-06-05 | ファーブル−クレイマー・ホールディングス・インコーポレイテッド | ゲピロンの高用量徐放性製剤 |
| ITMI20060629A1 (it) * | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| US20090088404A1 (en) | 2007-01-31 | 2009-04-02 | Methylation Sciences International Srl | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| KR20070093972A (ko) * | 2007-06-05 | 2007-09-19 | 파브르-크래머 홀딩스. 인크 | 게피론의 고용량 서방성 제제 |
| US7947662B2 (en) * | 2008-02-20 | 2011-05-24 | Gnosis S.P.A. | Folates, compositions and uses thereof |
| US20110027342A1 (en) | 2009-07-28 | 2011-02-03 | Msi Methylation Sciences, Inc. | S-adenosylmethionine formulations with enhanced bioavailability |
| US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| IT1401146B1 (it) * | 2010-07-27 | 2013-07-12 | Gnosis Spa | Composizione comprendente shellac e/o un suo sale e sodio amido glicolato |
-
2013
- 2013-11-18 IT IT001906A patent/ITMI20131906A1/it unknown
-
2014
- 2014-11-06 UA UAA201605352A patent/UA119856C2/uk unknown
- 2014-11-06 CN CN201480062634.8A patent/CN105764493B/zh active Active
- 2014-11-06 BR BR112016011142-7A patent/BR112016011142B1/pt active IP Right Grant
- 2014-11-06 HR HRP20220271TT patent/HRP20220271T1/hr unknown
- 2014-11-06 WO PCT/IB2014/065852 patent/WO2015071806A1/en not_active Ceased
- 2014-11-06 DK DK14812619.6T patent/DK3071191T3/da active
- 2014-11-06 MX MX2016006442A patent/MX367664B/es active IP Right Grant
- 2014-11-06 AU AU2014349782A patent/AU2014349782B2/en active Active
- 2014-11-06 US US15/037,149 patent/US10702482B2/en active Active
- 2014-11-06 JP JP2016532105A patent/JP6401270B2/ja active Active
- 2014-11-06 RS RS20220156A patent/RS62916B1/sr unknown
- 2014-11-06 PT PT148126196T patent/PT3071191T/pt unknown
- 2014-11-06 EP EP14812619.6A patent/EP3071191B1/en active Active
- 2014-11-06 KR KR1020167011680A patent/KR102224087B1/ko active Active
- 2014-11-06 PL PL14812619T patent/PL3071191T3/pl unknown
- 2014-11-06 HU HUE14812619A patent/HUE058086T2/hu unknown
- 2014-11-06 EA EA201691034A patent/EA039558B1/ru unknown
- 2014-11-06 LT LTEPPCT/IB2014/065852T patent/LT3071191T/lt unknown
- 2014-11-06 GE GEAP201414177A patent/GEP20186884B/en unknown
- 2014-11-06 ES ES14812619T patent/ES2908924T3/es active Active
- 2014-11-06 CA CA2929426A patent/CA2929426C/en active Active
- 2014-11-06 NZ NZ719000A patent/NZ719000A/en unknown
-
2016
- 2016-04-14 PH PH12016500693A patent/PH12016500693A1/en unknown
- 2016-04-17 IL IL245167A patent/IL245167B/en active IP Right Grant
- 2016-04-19 ZA ZA2016/02659A patent/ZA201602659B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241352A0 (en) | Compounds of pyruvate kinase plants, preparations containing them and their uses | |
| EP3018118A4 (en) | Base generator, base-reactive composition containing said base generator, and base generation method | |
| EP3016667A4 (en) | Oral compositions | |
| AU2014360597B2 (en) | Compositions and methods for making (R)-Reticuline and precursors thereof | |
| EP3058370A4 (en) | Methods and compositions for coronavirus diagnostics and therapeutics | |
| PH12016501034A1 (en) | Oral care compositions and methods | |
| PH12015502014A1 (en) | Racecadotril lipid compositions | |
| EP3041841A4 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
| GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
| GEP20186884B (en) | Slow-release solid oral compositions | |
| EP3075822A4 (en) | Perfume composition | |
| MX2015008588A (es) | Composiciones y metodos para la transfeccion de polinucleótidos. | |
| CA2875305C (en) | Fbxo3 inhibitors | |
| GB201600996D0 (en) | Magnetic powder, magnetic-powder composition, molded object of magnetic-powder composition, and processes for producing same | |
| SG10201801459SA (en) | Compositions and methods for live, attenuated alphavirus formulations | |
| MX354226B (es) | Composiciones para cuidado oral y métodos. | |
| EP3102540A4 (en) | Compositions including a vacancy-engineered (ve)-zno nanocomposite, methods of making a composition, methods of using a composition | |
| EP3090728A4 (en) | Oral composition | |
| MX357796B (es) | Composicion fungicida. | |
| EP3021460A4 (en) | Member for dynamo-electric machine, dynamo-electric machine, and resin composition | |
| MX2016008234A (es) | Composiciones para cuidado oral y metodos. | |
| EP3241564A4 (en) | Composition for forming complex, complex formed therefrom, and composition for oral ingestion, containing same | |
| SG11201807875XA (en) | Composition for improving oral cavity environment | |
| MY169177A (en) | Cocoa powder compositions | |
| EP3064075A4 (en) | Oral tobacco composition |